How Do We Add Value at Laurel Hollow Capital
Corporate Strategy
Mergers & Acquisitions
Business Development
Our client in China is looking to spin off its assets offshore and restructure corporate structure for both company development and exit considerations.
Business Development
Mergers & Acquisitions
Business Development
Our client in the US is looking for partners in China and Japan to further develop and commercialize its ground breaking technology in ophthalmology in those significant markets.
Mergers & Acquisitions
Mergers & Acquisitions
Asset In-Licensing/Out-Licensing
Our client is a Nasdaq listed biotech company looking to acquire another public listed company for synergistic pipeline assets as well as risk mitigation.
Asset In-Licensing/Out-Licensing
Asset In-Licensing/Out-Licensing
Asset In-Licensing/Out-Licensing
Our client is looking to out license its Phase II /III clinical stage assets. They already have a term sheet from a major pharmaceutical company but are looking to run a broader process to maximize asset value.
Financing
Asset In-Licensing/Out-Licensing
Global Reach
Our clients in the US, EU, Asia are earlier stage biotech/medtech companies looking to raise venture/growth capital from Series A to crossover pre-IPO rounds.
Global Reach
Asset In-Licensing/Out-Licensing
Global Reach
Our client in China is looking for commercial partners for its proprietary veterinary biologics in the US and EU markets.